China channel feed

Can a $1B IPO at­tract leery in­vestors on HKEX? WuXi AppTec is set to find out

7 years ago
Financing

Bio­Haven hopes to soothe Chi­nese headaches with Shang­hai sub­sidiary

7 years ago

At the cen­ter of a glob­al tem­pest, Jiankui He de­fends edit­ing the genes of 2 new­borns

7 years ago

In a land­mark first, Chi­nese sci­en­tist claims birth of ge­net­i­cal­ly mod­i­fied ba­bies — and all hell breaks loose

7 years ago

Seek­ing an edge in the glob­al I/O race, Al­pham­ab On­col­o­gy loads up $100M-plus from mar­quee back­ers

7 years ago
Financing

CStone braves the HKEX with late-stage plans brew­ing for new­ly beefed up I/O pipeline

7 years ago
Financing

In­novent, Eli Lil­ly cite a new suc­cess for their PD-1 in lung can­cer, with a like­ly pi­o­neer­ing ap­proval in Chi­na loom­ing

7 years ago
R&D

Fi­nal­ly! In­novent hikes on Hong Kong de­but amid cloudy mar­ket sen­ti­ments

7 years ago
Financing

Feds charge a group of Genen­tech vets with an­oth­er scheme to steal trade se­crets — this time to help a Tai­wanese biotech

7 years ago

WuXi dives in­to com­pu­ta­tion­al drug dis­cov­ery, launch­es New York-based JV with Schrödinger

7 years ago
Financing
AI

Terns scores $80M in Se­ries B fi­nanc­ing led by Vi­vo, Or­biMed

7 years ago
Financing

A pho­to log of my week in Shang­hai, host­ing the first an­nu­al US-Chi­na Bio­phar­ma In­no­va­tion and In­vest­ment Sum­mit

7 years ago

Hong Kong IPO de­liv­ers $421M to In­novent as an­oth­er one of Chi­na's biotech uni­corns hauls in big mon­ey

7 years ago
Financing

In­novent to seek $400M-plus on Hong Kong IPO, re­ports say; will it re­vive biotech's for­tunes on HKEX?

7 years ago
Financing

#BI­IS18 In­ter­view: Or­biMed Asi­a's Jonathan Wang on his up­bring­ing, de­cid­ing against a con­sult­ing ca­reer, blunt ad­vice for Chi­nese en­tre­pre­neurs, and more

7 years ago
People

Gen­script re­bounds on HKEX with staunch de­fense of Leg­end Biotech's CAR-T da­ta in­tegri­ty

7 years ago

Scathing short at­tack from an ob­scure source ac­cus­es Nan­jing Leg­end of ma­nip­u­lat­ing CAR-T da­ta — Gen­script shares nose­dive

7 years ago

With new $10.6B fund, Hill­house Cap­i­tal sets the stage for splashy Asia-fo­cused biotech deals

7 years ago
Financing
Startups

WuXi AppTec files for pub­lic list­ing in Hong Kong four months af­ter ex­plo­sive Shang­hai IPO

7 years ago
Financing
Outsourcing

An­oth­er sci­en­tist pleads guilty for his role in a scheme to sell GSK's trade se­crets in Chi­na

7 years ago
People
Pharma

Sanofi swaps top ex­ecs with Bay­er, trig­ger­ing a re­or­ga­ni­za­tion that puts Chi­na in the head­lights

7 years ago
People

Chi­nese phar­ma pow­er­house Han­soh joins fledg­ling biotechs in the Hong Kong IPO line

7 years ago
Financing

Chi-Med, Eli Lil­ly score a land­mark ap­proval in Chi­na for the first new can­cer drug de­vel­oped in Chi­na

7 years ago
Pharma

Glax­o­SmithK­line sci­en­tist cops a guilty plea in scheme to sell the phar­ma gi­ant's drug re­search in Chi­na

7 years ago
First page Previous page 22232425262728 Next page Last page
A service from the Financial Times